BACKGROUND: For a 1-day myocardial perfusion SPECT (MPS) the recommendations for administered activity stated in the EANM guidelines results in an effective dose of up to 16 mSv per patient. Recently, a gamma camera system, based on cadmium zinc telluride (CZT) technology, was introduced. This technique has the potential to reduce the effective dose and scan time compared to the conventional NaI gamma camera. The aim of this study was to investigate if the effective dose can be reduced with a preserved image quality using CZT technology in MPS. METHODS: In total, 150 patients were included in the study. All underwent a 1-day (99m)Tc-tetrofosmin stress-rest protocol and were divided into three subgroups (n = 50 in each group) with 4, 3, and 2.5 MBq/kg body weight of administered activity in the stress examination, respectively. The acquisition time was increased in proportion to the decrease in administered activity. All examinations were analyzed for image quality by visual grading on a 4-point scale (1 = poor, 2 = adequate, 3 = good, 4 = excellent), by two expert readers. RESULTS: The total effective dose (stress + rest) decreased from 9.3 to 5.8 mSv comparing 4 to 2.5 MBq/kg body weight. For the patients undergoing stress examination only (35%) the effective dose, administrating 2.5 MBq/kg, was 1.4 mSv. The image acquisition times for 2.5 MBq/kg body weight were 475 and 300 seconds (stress and rest) compared to 900 seconds for each when using conventional MPS. The average image quality was 3.7 ± 0.5, 3.8 ± 0.5, and 3.8 ± 0.4 for the stress images and 3.5 ± 0.6, 3.6 ± 0.6, and 3.5 ± 0.6 for the rest images and showed no statistically significant difference (P = .62) among the 4, 3, and 2.5 MBq/kg groups. CONCLUSIONS: The new CZT technology can be used to considerably decrease the effective dose and acquisition time for MPS with preserved high image quality.
BACKGROUND: For a 1-day myocardial perfusion SPECT (MPS) the recommendations for administered activity stated in the EANM guidelines results in an effective dose of up to 16 mSv per patient. Recently, a gamma camera system, based on cadmium zinc telluride (CZT) technology, was introduced. This technique has the potential to reduce the effective dose and scan time compared to the conventional NaI gamma camera. The aim of this study was to investigate if the effective dose can be reduced with a preserved image quality using CZT technology in MPS. METHODS: In total, 150 patients were included in the study. All underwent a 1-day (99m)Tc-tetrofosmin stress-rest protocol and were divided into three subgroups (n = 50 in each group) with 4, 3, and 2.5 MBq/kg body weight of administered activity in the stress examination, respectively. The acquisition time was increased in proportion to the decrease in administered activity. All examinations were analyzed for image quality by visual grading on a 4-point scale (1 = poor, 2 = adequate, 3 = good, 4 = excellent), by two expert readers. RESULTS: The total effective dose (stress + rest) decreased from 9.3 to 5.8 mSv comparing 4 to 2.5 MBq/kg body weight. For the patients undergoing stress examination only (35%) the effective dose, administrating 2.5 MBq/kg, was 1.4 mSv. The image acquisition times for 2.5 MBq/kg body weight were 475 and 300 seconds (stress and rest) compared to 900 seconds for each when using conventional MPS. The average image quality was 3.7 ± 0.5, 3.8 ± 0.5, and 3.8 ± 0.4 for the stress images and 3.5 ± 0.6, 3.6 ± 0.6, and 3.5 ± 0.6 for the rest images and showed no statistically significant difference (P = .62) among the 4, 3, and 2.5 MBq/kg groups. CONCLUSIONS: The new CZT technology can be used to considerably decrease the effective dose and acquisition time for MPS with preserved high image quality.
Authors: B Hesse; T B Lindhardt; W Acampa; C Anagnostopoulos; J Ballinger; J J Bax; L Edenbrandt; A Flotats; G Germano; T Gmeiner Stopar; P Franken; A Kelion; A Kjaer; D Le Guludec; M Ljungberg; A F Maenhout; C Marcassa; J Marving; F McKiddie; W M Schaefer; L Stegger; R Underwood Journal: Eur J Nucl Med Mol Imaging Date: 2008-04 Impact factor: 9.236
Authors: Sanjiv S Gambhir; Daniel S Berman; Jack Ziffer; Michael Nagler; Martin Sandler; Jim Patton; Brian Hutton; Tali Sharir; Shlomo Ben Haim; Simona Ben Haim Journal: J Nucl Med Date: 2009-04 Impact factor: 10.057
Authors: Moshe Bocher; Ira M Blevis; Leonid Tsukerman; Yigal Shrem; Gil Kovalski; Lana Volokh Journal: Eur J Nucl Med Mol Imaging Date: 2010-06-29 Impact factor: 9.236
Authors: Mark J Eisenberg; Jonathan Afilalo; Patrick R Lawler; Michal Abrahamowicz; Hugues Richard; Louise Pilote Journal: CMAJ Date: 2011-02-07 Impact factor: 8.262
Authors: W Lane Duvall; Lori B Croft; Eric S Ginsberg; Andrew J Einstein; Krista A Guma; Titus George; Milena J Henzlova Journal: J Nucl Cardiol Date: 2011-04-29 Impact factor: 5.952
Authors: Daniel S Berman; Xingping Kang; Balaji Tamarappoo; Arik Wolak; Sean W Hayes; Ryo Nakazato; Louise E J Thomson; Faith Kite; Ishac Cohen; Piotr J Slomka; Andrew J Einstein; John D Friedman Journal: JACC Cardiovasc Imaging Date: 2009-03
Authors: Fabio P Esteves; Paolo Raggi; Russell D Folks; Zohar Keidar; J Wells Askew; Shmuel Rispler; Michael K O'Connor; Liudmilla Verdes; Ernest V Garcia Journal: J Nucl Cardiol Date: 2009-08-18 Impact factor: 5.952
Authors: Andrew J Einstein; Ron Blankstein; Howard Andrews; Mathews Fish; Richard Padgett; Sean W Hayes; John D Friedman; Mehreen Qureshi; Harivony Rakotoarivelo; Piotr Slomka; Ryo Nakazato; Sabahat Bokhari; Marcello Di Carli; Daniel S Berman Journal: J Nucl Med Date: 2014-06-30 Impact factor: 10.057
Authors: Ronaldo S L Lima; Thaís R Peclat; Ana Carolina A H Souza; Aline M K Nakamoto; Felipe M Neves; Victor F Souza; Letícia B Glerian; Andrea De Lorenzo Journal: Int J Cardiovasc Imaging Date: 2017-06-29 Impact factor: 2.357
Authors: Ami E Iskandrian; Vasken Dilsizian; Ernest V Garcia; Rob S Beanlands; Manuel Cerqueira; Prem Soman; Daniel S Berman; Alberto Cuocolo; Andrew J Einstein; Charity J Morgan; Fadi G Hage; Heinrich R Schelbert; Jeroen J Bax; Joseph C Wu; Leslee J Shaw; Mehran M Sadeghi; Nagara Tamaki; Philipp A Kaufmann; Robert Gropler; Sharmila Dorbala; William Van Decker Journal: J Nucl Cardiol Date: 2017-11-06 Impact factor: 5.952